Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis Mireen Friedrich-Rust, Nina Schlueter, Christina Smaczny, Olaf Eickmeier, Martin Rosewich, Kirstin Feifel, Eva Herrmann, Thierry Poynard, Wolfgang Gleiber, Christoph Lais, Stefan Zielen, Thomas O.F. Wagner, Stefan Zeuzem, Joerg Bojunga Journal of Cystic Fibrosis Volume 12, Issue 5, Pages 431-439 (September 2013) DOI: 10.1016/j.jcf.2012.12.013 Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions
Fig. 1 B-mode ultrasound of the right liver-lobe using the S2000, 4C1-probe at 4MHz probe with the ROI placed 2cm below the liver capsule with a depth of 3.6cm below the skin. ARFI velocity within the ROI measures 0.87m/s. Journal of Cystic Fibrosis 2013 12, 431-439DOI: (10.1016/j.jcf.2012.12.013) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions
Fig. 2 Histogram for the prevalence of liver-fibrosis stages (%) using Transient Elastography, ARFI-imaging, and Fibrotest. The following abbreviations were used: TE-itd = results for transient elastography according to the intention to diagnose analysis; TE-pp = per protocol results of transient elastography; ARFI-rll = ARFI of the right liver lobe; ARFI-lll = ARFI of the left liver lobe; FT = Fibrotest; and FT-cbh = Fibrotest corrected by haptoglobin. Journal of Cystic Fibrosis 2013 12, 431-439DOI: (10.1016/j.jcf.2012.12.013) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions